These results indicated that miR-193a could destroy intercellular junctions of pancreatic cancer cells, and promote metastasis through inhibiting TGF-β2/TGF-βRIII/ARHGEF15/ABL2 signaling. This evidence concerns the gene ABL2 and familial pancreatic carcinoma.